Gennex Laboratories Limited

₹9.11As of Sun 8 Nov 2026, 12:00 UTC
BSE:531739Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 2.90%
Div yield —
ROE 9.82%
Pharmaceutical Preparations
Beta (5Y) 1.12
PE TTM 12.29
TSR TTM (44.55%)
Mkt cap ₹2.213B
ROIC 6.42%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹11
18.46%
(4.20%)
Hold 10|5|5|2|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.13
0.13
0.13
0.13
12.21%
12.28%
6.30%
1.53%
Revenue₹M
286.3
298.6
300.1
294.3
7.16%
5.82%
3.97%
1.92%
Peers (US$23.28M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.526
(0.734)
(0.637)
EBIT/Intx
1.174
0.140
0.148
Own earn%
(78.23)
(33.68)
(20.54)
Sh yield%
29.47
41.71
39.70
Owners
Insiders/Inst%
11.21
48.53
Short interest%
1.08
SBC / revenue%
2.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
19–24
$1 testx
0.0
Incr. ROIC%
2